Compare GIC & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIC | GLUE |
|---|---|---|
| Founded | 1949 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 1995 | 2021 |
| Metric | GIC | GLUE |
|---|---|---|
| Price | $29.80 | $16.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 97.1K | ★ 812.4K |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.47% | N/A |
| EPS Growth | ★ 2.63 | N/A |
| EPS | ★ 1.75 | 0.25 |
| Revenue | ★ $1,335,800,000.00 | $181,538,000.00 |
| Revenue This Year | $4.26 | $81.52 |
| Revenue Next Year | $3.64 | N/A |
| P/E Ratio | ★ $17.10 | $64.61 |
| Revenue Growth | 0.16 | ★ 1112.27 |
| 52 Week Low | $20.79 | $3.50 |
| 52 Week High | $38.79 | $18.15 |
| Indicator | GIC | GLUE |
|---|---|---|
| Relative Strength Index (RSI) | 59.25 | 58.56 |
| Support Level | $29.37 | $15.21 |
| Resistance Level | $28.93 | $17.75 |
| Average True Range (ATR) | 0.63 | 0.87 |
| MACD | 0.41 | -0.17 |
| Stochastic Oscillator | 80.69 | 40.46 |
Global Industrial Co is a value-added industrial distributor. The company distributes a wide range of industrial and maintenance, repair, and operations (MRO) products to customers across North America, including storage and shelving, safety and security, carts and trucks, HVAC and fans, furniture and decor, material handling, janitorial and facility maintenance, workbenches and shop desks, tools and instruments, plumbing and pumps, office and school supplies, packaging and shipping, lighting and electrical, food service and retail, medical and laboratory, motors and power transmission, building supplies, machining, fasteners and hardware, vehicle maintenance, and raw materials.
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.